NSEResignation22h ago · 19 Aug 2026, 06:35 pm

Resignation

Tatva Chintan Pharma Chem Limited · TATVA

✦ AI SummaryMgmt Change

Tatva Chintan Pharma Chem Limited has informed the Exchange regarding the resignation of a Senior Management Personnel, Mr. Ajay Rawat, Assistant Vice President – Research and Development, effective from 13 November 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Tatva Chintan Pharma Chem Limited has informed the Exchange regarding Resignation of a Senior Management Personnel of the Company.

Attachments (1)

📄

TATVA_19082026183430_RSMP.pdf

pdf

Download →
View document text
Date: 19 August 2026 Ref. No.: TCPCL/SEC/2026-27/00037 The General Manager, The Manager, Corporate relationship department, Listing department, BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block-G, Dalal Street, Fort, Bandra-Kurla Complex, Bandra(E), Mumbai-400 001 Mumbai-400 051 Scrip Code: 543321 Scrip Symbol: TATVA Subject: Intimation of Resignation of Senior Management Personnel of the Company, under Regulations 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. Dear Sir/Madam, Pursuant to the provisions of Regulation 30 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), we hereby inform you that Mr. Ajay Rawat, Assistant Vice President – Research and Development, designated as a Senior Management Personnel of the Company, vide his letter dated 14 August 2026 has submitted his resignation. The said resignation has been accepted by the management of the Company on 19 August 2026 and the resignation shall be effective from the close of business hours on 13 November 2026. Disclosure under Regulation 30 of the SEBI Listing Regulations read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 issued on 11 July 2023 and last updated on 30 January 2026 for the aforesaid matter is enclosed herewith as Annexure A, along with a copy of the resignation letter. The above information shall be made available on the website of the Company at www.tatvachintan.com. Kindly take above intimation on your record and oblige. Thanking you, Yours faithfully, For Tatva Chintan Pharma Chem Limited Ishwar Nayi Company Secretary and Compliance Officer M. No.: A37444 Encl.: As above Disclosure under Regulation 30 of the SEBI Listing Regulations read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 issued on 11 July 2023 and last updated on 30 January 2026. Annexure A Sr. Particulars Mr. Ajay Rawat No. (Assistant Vice President – Research and Development, designated as a Senior Management Personnel) 1. Reason for change viz. appointment, Mr. Ajay Rawat, Assistant Vice President – Research and Development, re-appointment, resignation, removal, designated as a Senior Management Personnel of the Company, has tendered death or otherwise his resignation for reasons as mentioned in the attached resignation letter. 2. Date of appointment / re-appointment / Cessation will be effective from the close of business hours on cessation (as applicable) & term of 13 November 2026. appointment / re-appointment 3. Brief profile (in case of appointment) Not Applicable 4. Disclosure of Relationship between Not Applicable Directors (in case of appointment as a Director) 5. Information as required pursuant to Not Applicable BSE Circular with ref. no. LIST/COMP/14/2018-19 and the National Stock Exchange of India Ltd with ref. no. NSE/CML/2018/24, both dated 20 June 2018